Genmab A/S (GMAB)
38.48
+3.73
(+10.73%)
USD |
NASDAQ |
Oct 05, 16:00
38.74
+0.26
(+0.68%)
After-Hours: 04:12
Genmab Gross Profit Margin (Quarterly) : 92.73% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.73% |
| March 31, 2026 | 92.75% |
| December 31, 2025 | 92.34% |
| September 30, 2025 | 94.32% |
| June 30, 2025 | 93.84% |
| March 31, 2025 | 94.13% |
| December 31, 2024 | 94.77% |
| September 30, 2024 | 95.07% |
| June 30, 2024 | 96.48% |
| March 31, 2024 | 95.53% |
| December 31, 2023 | 97.31% |
| September 30, 2023 | 98.32% |
| June 30, 2023 | 99.50% |
| March 31, 2023 | 0.00% |
| December 31, 2022 | 0.00% |
| September 30, 2022 | 0.00% |
| June 30, 2022 | 0.00% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ascendis Pharma A/S | 90.64% |
| Zealand Pharma A/S | 99.76% |
| AbbVie, Inc. | 74.71% |
| Bavarian Nordic A/S | 60.45% |
| Evaxion AS | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.77% |
| Return on Assets | 7.67% |
| Return on Invested Capital | 8.76% |
| Profit Margin (Quarterly) | 26.23% |
| Operating Margin (Quarterly) | 35.24% |
| Return on Net Operating Assets | 10.40% |